The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Gastritis Drugs Market Research Report 2025
Synopsis
The global OTC Gastritis Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for OTC Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for OTC Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of OTC Gastritis Drugs include GSK, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for OTC Gastritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Gastritis Drugs.
Report Scope
The OTC Gastritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Gastritis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Gastritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
China Resources Sanjiu Pharmaceutical
Sunflower Pharmaceutical
Livzon Pharmaceutical
Segment by Type
Chinese Patent Medicine
Western Medicine
Segment by Application
Hospital
Drug Store
Online Supermarket
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Gastritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Gastritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global OTC Gastritis Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for OTC Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for OTC Gastritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of OTC Gastritis Drugs include GSK, Pfizer, Johnson & Johnson, Bayer, Procter & Gamble, Perrigo, Abbott, Sanofi and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for OTC Gastritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Gastritis Drugs.
Report Scope
The OTC Gastritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Gastritis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Gastritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
China Resources Sanjiu Pharmaceutical
Sunflower Pharmaceutical
Livzon Pharmaceutical
Segment by Type
Chinese Patent Medicine
Western Medicine
Segment by Application
Hospital
Drug Store
Online Supermarket
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of OTC Gastritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of OTC Gastritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 OTC Gastritis Drugs Market Overview
1.1 Product Overview and Scope of OTC Gastritis Drugs
1.2 OTC Gastritis Drugs Segment by Type
1.2.1 Global OTC Gastritis Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Chinese Patent Medicine
1.2.3 Western Medicine
1.3 OTC Gastritis Drugs Segment by Application
1.3.1 Global OTC Gastritis Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Supermarket
1.3.5 Others
1.4 Global OTC Gastritis Drugs Market Size Estimates and Forecasts
1.4.1 Global OTC Gastritis Drugs Revenue 2019-2030
1.4.2 Global OTC Gastritis Drugs Sales 2019-2030
1.4.3 Global OTC Gastritis Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 OTC Gastritis Drugs Market Competition by Manufacturers
2.1 Global OTC Gastritis Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global OTC Gastritis Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global OTC Gastritis Drugs Average Price by Manufacturers (2019-2024)
2.4 Global OTC Gastritis Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of OTC Gastritis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Gastritis Drugs, Product Type & Application
2.7 OTC Gastritis Drugs Market Competitive Situation and Trends
2.7.1 OTC Gastritis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OTC Gastritis Drugs Players Market Share by Revenue
2.7.3 Global OTC Gastritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OTC Gastritis Drugs Retrospective Market Scenario by Region
3.1 Global OTC Gastritis Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global OTC Gastritis Drugs Global OTC Gastritis Drugs Sales by Region: 2019-2030
3.2.1 Global OTC Gastritis Drugs Sales by Region: 2019-2024
3.2.2 Global OTC Gastritis Drugs Sales by Region: 2025-2030
3.3 Global OTC Gastritis Drugs Global OTC Gastritis Drugs Revenue by Region: 2019-2030
3.3.1 Global OTC Gastritis Drugs Revenue by Region: 2019-2024
3.3.2 Global OTC Gastritis Drugs Revenue by Region: 2025-2030
3.4 North America OTC Gastritis Drugs Market Facts & Figures by Country
3.4.1 North America OTC Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America OTC Gastritis Drugs Sales by Country (2019-2030)
3.4.3 North America OTC Gastritis Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Gastritis Drugs Market Facts & Figures by Country
3.5.1 Europe OTC Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe OTC Gastritis Drugs Sales by Country (2019-2030)
3.5.3 Europe OTC Gastritis Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific OTC Gastritis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific OTC Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific OTC Gastritis Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific OTC Gastritis Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America OTC Gastritis Drugs Market Facts & Figures by Country
3.7.1 Latin America OTC Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America OTC Gastritis Drugs Sales by Country (2019-2030)
3.7.3 Latin America OTC Gastritis Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Gastritis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Gastritis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa OTC Gastritis Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa OTC Gastritis Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Gastritis Drugs Sales by Type (2019-2030)
4.1.1 Global OTC Gastritis Drugs Sales by Type (2019-2024)
4.1.2 Global OTC Gastritis Drugs Sales by Type (2025-2030)
4.1.3 Global OTC Gastritis Drugs Sales Market Share by Type (2019-2030)
4.2 Global OTC Gastritis Drugs Revenue by Type (2019-2030)
4.2.1 Global OTC Gastritis Drugs Revenue by Type (2019-2024)
4.2.2 Global OTC Gastritis Drugs Revenue by Type (2025-2030)
4.2.3 Global OTC Gastritis Drugs Revenue Market Share by Type (2019-2030)
4.3 Global OTC Gastritis Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global OTC Gastritis Drugs Sales by Application (2019-2030)
5.1.1 Global OTC Gastritis Drugs Sales by Application (2019-2024)
5.1.2 Global OTC Gastritis Drugs Sales by Application (2025-2030)
5.1.3 Global OTC Gastritis Drugs Sales Market Share by Application (2019-2030)
5.2 Global OTC Gastritis Drugs Revenue by Application (2019-2030)
5.2.1 Global OTC Gastritis Drugs Revenue by Application (2019-2024)
5.2.2 Global OTC Gastritis Drugs Revenue by Application (2025-2030)
5.2.3 Global OTC Gastritis Drugs Revenue Market Share by Application (2019-2030)
5.3 Global OTC Gastritis Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK OTC Gastritis Drugs Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer OTC Gastritis Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson OTC Gastritis Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer OTC Gastritis Drugs Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Procter & Gamble
6.5.1 Procter & Gamble Corporation Information
6.5.2 Procter & Gamble Description and Business Overview
6.5.3 Procter & Gamble OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Procter & Gamble OTC Gastritis Drugs Product Portfolio
6.5.5 Procter & Gamble Recent Developments/Updates
6.6 Perrigo
6.6.1 Perrigo Corporation Information
6.6.2 Perrigo Description and Business Overview
6.6.3 Perrigo OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Perrigo OTC Gastritis Drugs Product Portfolio
6.6.5 Perrigo Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott OTC Gastritis Drugs Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi OTC Gastritis Drugs Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Corporation Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical OTC Gastritis Drugs Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Nestle
6.10.1 Nestle Corporation Information
6.10.2 Nestle Description and Business Overview
6.10.3 Nestle OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nestle OTC Gastritis Drugs Product Portfolio
6.10.5 Nestle Recent Developments/Updates
6.11 Boehringer Ingelheim
6.11.1 Boehringer Ingelheim Corporation Information
6.11.2 Boehringer Ingelheim OTC Gastritis Drugs Description and Business Overview
6.11.3 Boehringer Ingelheim OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Boehringer Ingelheim OTC Gastritis Drugs Product Portfolio
6.11.5 Boehringer Ingelheim Recent Developments/Updates
6.12 Reckitt Benckiser
6.12.1 Reckitt Benckiser Corporation Information
6.12.2 Reckitt Benckiser OTC Gastritis Drugs Description and Business Overview
6.12.3 Reckitt Benckiser OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Reckitt Benckiser OTC Gastritis Drugs Product Portfolio
6.12.5 Reckitt Benckiser Recent Developments/Updates
6.13 Purdue Pharma
6.13.1 Purdue Pharma Corporation Information
6.13.2 Purdue Pharma OTC Gastritis Drugs Description and Business Overview
6.13.3 Purdue Pharma OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Purdue Pharma OTC Gastritis Drugs Product Portfolio
6.13.5 Purdue Pharma Recent Developments/Updates
6.14 China Resources Sanjiu Pharmaceutical
6.14.1 China Resources Sanjiu Pharmaceutical Corporation Information
6.14.2 China Resources Sanjiu Pharmaceutical OTC Gastritis Drugs Description and Business Overview
6.14.3 China Resources Sanjiu Pharmaceutical OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 China Resources Sanjiu Pharmaceutical OTC Gastritis Drugs Product Portfolio
6.14.5 China Resources Sanjiu Pharmaceutical Recent Developments/Updates
6.15 Sunflower Pharmaceutical
6.15.1 Sunflower Pharmaceutical Corporation Information
6.15.2 Sunflower Pharmaceutical OTC Gastritis Drugs Description and Business Overview
6.15.3 Sunflower Pharmaceutical OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sunflower Pharmaceutical OTC Gastritis Drugs Product Portfolio
6.15.5 Sunflower Pharmaceutical Recent Developments/Updates
6.16 Livzon Pharmaceutical
6.16.1 Livzon Pharmaceutical Corporation Information
6.16.2 Livzon Pharmaceutical OTC Gastritis Drugs Description and Business Overview
6.16.3 Livzon Pharmaceutical OTC Gastritis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Livzon Pharmaceutical OTC Gastritis Drugs Product Portfolio
6.16.5 Livzon Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Gastritis Drugs Industry Chain Analysis
7.2 OTC Gastritis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Gastritis Drugs Production Mode & Process
7.4 OTC Gastritis Drugs Sales and Marketing
7.4.1 OTC Gastritis Drugs Sales Channels
7.4.2 OTC Gastritis Drugs Distributors
7.5 OTC Gastritis Drugs Customers
8 OTC Gastritis Drugs Market Dynamics
8.1 OTC Gastritis Drugs Industry Trends
8.2 OTC Gastritis Drugs Market Drivers
8.3 OTC Gastritis Drugs Market Challenges
8.4 OTC Gastritis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global OTC Gastritis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global OTC Gastritis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global OTC Gastritis Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global OTC Gastritis Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global OTC Gastritis Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global OTC Gastritis Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global OTC Gastritis Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market OTC Gastritis Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of OTC Gastritis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of OTC Gastritis Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of OTC Gastritis Drugs, Product Type & Application
Table 12. Global Key Manufacturers of OTC Gastritis Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Gastritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Gastritis Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OTC Gastritis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global OTC Gastritis Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global OTC Gastritis Drugs Sales Market Share by Region (2019-2024)
Table 19. Global OTC Gastritis Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global OTC Gastritis Drugs Sales Market Share by Region (2025-2030)
Table 21. Global OTC Gastritis Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global OTC Gastritis Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global OTC Gastritis Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global OTC Gastritis Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America OTC Gastritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America OTC Gastritis Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America OTC Gastritis Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America OTC Gastritis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America OTC Gastritis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe OTC Gastritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe OTC Gastritis Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe OTC Gastritis Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe OTC Gastritis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe OTC Gastritis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific OTC Gastritis Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific OTC Gastritis Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific OTC Gastritis Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific OTC Gastritis Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific OTC Gastritis Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America OTC Gastritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America OTC Gastritis Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America OTC Gastritis Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America OTC Gastritis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America OTC Gastritis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa OTC Gastritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa OTC Gastritis Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa OTC Gastritis Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa OTC Gastritis Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa OTC Gastritis Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global OTC Gastritis Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global OTC Gastritis Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global OTC Gastritis Drugs Sales Market Share by Type (2019-2024)
Table 53. Global OTC Gastritis Drugs Sales Market Share by Type (2025-2030)
Table 54. Global OTC Gastritis Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global OTC Gastritis Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global OTC Gastritis Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global OTC Gastritis Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global OTC Gastritis Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global OTC Gastritis Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global OTC Gastritis Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global OTC Gastritis Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global OTC Gastritis Drugs Sales Market Share by Application (2019-2024)
Table 63. Global OTC Gastritis Drugs Sales Market Share by Application (2025-2030)
Table 64. Global OTC Gastritis Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global OTC Gastritis Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global OTC Gastritis Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global OTC Gastritis Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global OTC Gastritis Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global OTC Gastritis Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GSK OTC Gastritis Drugs Product
Table 74. GSK Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer OTC Gastritis Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson OTC Gastritis Drugs Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Bayer OTC Gastritis Drugs Product
Table 89. Bayer Recent Developments/Updates
Table 90. Procter & Gamble Corporation Information
Table 91. Procter & Gamble Description and Business Overview
Table 92. Procter & Gamble OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Procter & Gamble OTC Gastritis Drugs Product
Table 94. Procter & Gamble Recent Developments/Updates
Table 95. Perrigo Corporation Information
Table 96. Perrigo Description and Business Overview
Table 97. Perrigo OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Perrigo OTC Gastritis Drugs Product
Table 99. Perrigo Recent Developments/Updates
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Abbott OTC Gastritis Drugs Product
Table 104. Abbott Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sanofi OTC Gastritis Drugs Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Teva Pharmaceutical Corporation Information
Table 111. Teva Pharmaceutical Description and Business Overview
Table 112. Teva Pharmaceutical OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Teva Pharmaceutical OTC Gastritis Drugs Product
Table 114. Teva Pharmaceutical Recent Developments/Updates
Table 115. Nestle Corporation Information
Table 116. Nestle Description and Business Overview
Table 117. Nestle OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Nestle OTC Gastritis Drugs Product
Table 119. Nestle Recent Developments/Updates
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Business Overview
Table 122. Boehringer Ingelheim OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Boehringer Ingelheim OTC Gastritis Drugs Product
Table 124. Boehringer Ingelheim Recent Developments/Updates
Table 125. Reckitt Benckiser Corporation Information
Table 126. Reckitt Benckiser Description and Business Overview
Table 127. Reckitt Benckiser OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Reckitt Benckiser OTC Gastritis Drugs Product
Table 129. Reckitt Benckiser Recent Developments/Updates
Table 130. Purdue Pharma Corporation Information
Table 131. Purdue Pharma Description and Business Overview
Table 132. Purdue Pharma OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Purdue Pharma OTC Gastritis Drugs Product
Table 134. Purdue Pharma Recent Developments/Updates
Table 135. China Resources Sanjiu Pharmaceutical Corporation Information
Table 136. China Resources Sanjiu Pharmaceutical Description and Business Overview
Table 137. China Resources Sanjiu Pharmaceutical OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. China Resources Sanjiu Pharmaceutical OTC Gastritis Drugs Product
Table 139. China Resources Sanjiu Pharmaceutical Recent Developments/Updates
Table 140. Sunflower Pharmaceutical Corporation Information
Table 141. Sunflower Pharmaceutical Description and Business Overview
Table 142. Sunflower Pharmaceutical OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Sunflower Pharmaceutical OTC Gastritis Drugs Product
Table 144. Sunflower Pharmaceutical Recent Developments/Updates
Table 145. Livzon Pharmaceutical Corporation Information
Table 146. Livzon Pharmaceutical Description and Business Overview
Table 147. Livzon Pharmaceutical OTC Gastritis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Livzon Pharmaceutical OTC Gastritis Drugs Product
Table 149. Livzon Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. OTC Gastritis Drugs Distributors List
Table 153. OTC Gastritis Drugs Customers List
Table 154. OTC Gastritis Drugs Market Trends
Table 155. OTC Gastritis Drugs Market Drivers
Table 156. OTC Gastritis Drugs Market Challenges
Table 157. OTC Gastritis Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of OTC Gastritis Drugs
Figure 2. Global OTC Gastritis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global OTC Gastritis Drugs Market Share by Type in 2023 & 2030
Figure 4. Chinese Patent Medicine Product Picture
Figure 5. Western Medicine Product Picture
Figure 6. Global OTC Gastritis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global OTC Gastritis Drugs Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Online Supermarket
Figure 11. Others
Figure 12. Global OTC Gastritis Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global OTC Gastritis Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global OTC Gastritis Drugs Sales (2019-2030) & (K Units)
Figure 15. Global OTC Gastritis Drugs Average Price (US$/Unit) & (2019-2030)
Figure 16. OTC Gastritis Drugs Report Years Considered
Figure 17. OTC Gastritis Drugs Sales Share by Manufacturers in 2023
Figure 18. Global OTC Gastritis Drugs Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest OTC Gastritis Drugs Players: Market Share by Revenue in 2023
Figure 20. OTC Gastritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global OTC Gastritis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America OTC Gastritis Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America OTC Gastritis Drugs Revenue Market Share by Country (2019-2030)
Figure 24. United States OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe OTC Gastritis Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe OTC Gastritis Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Netherlands OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific OTC Gastritis Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific OTC Gastritis Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America OTC Gastritis Drugs Sales Market Share by Country (2019-2030)
Figure 43. Latin America OTC Gastritis Drugs Revenue Market Share by Country (2019-2030)
Figure 44. Mexico OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa OTC Gastritis Drugs Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa OTC Gastritis Drugs Revenue Market Share by Country (2019-2030)
Figure 49. Turkey OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE OTC Gastritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of OTC Gastritis Drugs by Type (2019-2030)
Figure 53. Global Revenue Market Share of OTC Gastritis Drugs by Type (2019-2030)
Figure 54. Global OTC Gastritis Drugs Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of OTC Gastritis Drugs by Application (2019-2030)
Figure 56. Global Revenue Market Share of OTC Gastritis Drugs by Application (2019-2030)
Figure 57. Global OTC Gastritis Drugs Price (US$/Unit) by Application (2019-2030)
Figure 58. OTC Gastritis Drugs Value Chain
Figure 59. OTC Gastritis Drugs Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
